PL2176250T3 - Podstawione pochodne heteroarylpiperydyny jako modulatory receptora melanokortyny-4 - Google Patents
Podstawione pochodne heteroarylpiperydyny jako modulatory receptora melanokortyny-4Info
- Publication number
- PL2176250T3 PL2176250T3 PL08784892T PL08784892T PL2176250T3 PL 2176250 T3 PL2176250 T3 PL 2176250T3 PL 08784892 T PL08784892 T PL 08784892T PL 08784892 T PL08784892 T PL 08784892T PL 2176250 T3 PL2176250 T3 PL 2176250T3
- Authority
- PL
- Poland
- Prior art keywords
- melanocortin
- receptor modulators
- disorders
- diseases
- heteroarylpiperidine derivatives
- Prior art date
Links
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 title abstract 4
- 102000001796 Melanocortin 4 receptors Human genes 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 abstract 3
- 239000000556 agonist Substances 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 102000057094 human MC4R Human genes 0.000 abstract 1
- 201000000585 muscular atrophy Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95067607P | 2007-07-19 | 2007-07-19 | |
| EP07014219A EP2019100A1 (en) | 2007-07-19 | 2007-07-19 | Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| PCT/EP2008/005913 WO2009010299A1 (en) | 2007-07-19 | 2008-07-18 | Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| EP08784892A EP2176250B1 (en) | 2007-07-19 | 2008-07-18 | Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2176250T3 true PL2176250T3 (pl) | 2012-03-30 |
Family
ID=38728783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08784892T PL2176250T3 (pl) | 2007-07-19 | 2008-07-18 | Podstawione pochodne heteroarylpiperydyny jako modulatory receptora melanokortyny-4 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20100249093A1 (pl) |
| EP (2) | EP2019100A1 (pl) |
| JP (1) | JP2010533666A (pl) |
| KR (1) | KR20100033541A (pl) |
| CN (1) | CN101801950A (pl) |
| AT (1) | ATE530541T1 (pl) |
| AU (1) | AU2008277916B2 (pl) |
| BR (1) | BRPI0814382A2 (pl) |
| CA (1) | CA2694480C (pl) |
| DK (1) | DK2176250T3 (pl) |
| ES (1) | ES2371626T3 (pl) |
| HR (1) | HRP20110860T1 (pl) |
| IL (1) | IL202797A0 (pl) |
| NZ (1) | NZ582153A (pl) |
| PL (1) | PL2176250T3 (pl) |
| PT (1) | PT2176250E (pl) |
| RU (1) | RU2452734C2 (pl) |
| SI (1) | SI2176250T1 (pl) |
| WO (1) | WO2009010299A1 (pl) |
| ZA (1) | ZA201000153B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010011394A (es) | 2008-04-16 | 2010-11-12 | Angus Chemical | Hidrocarburos nitrados, derivados y procesos para su fabricacion. |
| EP2280925B1 (en) * | 2008-04-16 | 2013-08-14 | Angus Chemical Company | Process for the manufacture of nitropropanes |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| HRP20211950T1 (hr) | 2011-12-29 | 2022-03-18 | Rhythm Pharmaceuticals, Inc. | Postupak liječenja poremećaja u vezi sa melanokortin-4 receptorom u heterozigotnim nosiocima |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| WO2013174962A1 (en) | 2012-05-25 | 2013-11-28 | Janssen R&D Ireland | Uracyl spirooxetane nucleosides |
| US9663513B2 (en) | 2012-11-20 | 2017-05-30 | Merck Sharp & Dohme Corp. | Pyrimidine PDE10 inhibitors |
| CN110684067A (zh) | 2012-12-21 | 2020-01-14 | 艾丽奥斯生物制药有限公司 | 取代的核苷和核苷酸 |
| SG10202101510XA (en) | 2015-09-30 | 2021-03-30 | Rhythm Pharmaceuticals Inc | Method of treating melanocortin-4 receptor pathway-associated disorders |
| EP3773897A1 (en) | 2018-04-06 | 2021-02-17 | Rhythm Pharmaceuticals, Inc. | Compositions for treating kidney disease |
| FI3873903T3 (fi) | 2018-10-31 | 2024-03-26 | Gilead Sciences Inc | Substituoituja 6-azabentsiimidatsoliyhdisteitä HPK1-inhibiittoreina |
| KR102658602B1 (ko) | 2018-10-31 | 2024-04-19 | 길리애드 사이언시즈, 인코포레이티드 | Hpk1 억제 활성을 갖는 치환된 6-아자벤즈이미다졸 화합물 |
| CN109879766A (zh) * | 2019-03-02 | 2019-06-14 | 台州保灵药业有限公司 | 一种3-(nn-二甲基）氨基丁醇的合成方法 |
| TWI826690B (zh) | 2019-05-23 | 2023-12-21 | 美商基利科學股份有限公司 | 經取代之烯吲哚酮化物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2432985A1 (en) * | 2001-01-23 | 2002-08-01 | Vincent Mancuso | Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| US6977264B2 (en) * | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
| US20040010010A1 (en) * | 2002-04-30 | 2004-01-15 | Ebetino Frank Hallock | Melanocortin receptor ligands |
| AU2003268493A1 (en) * | 2002-09-11 | 2004-04-30 | Merck & Co., Inc. | Piperazine urea derivatives as melanocortin-4 receptor agonists |
| KR20050045927A (ko) * | 2003-11-12 | 2005-05-17 | 주식회사 엘지생명과학 | 멜라노코틴 수용체의 항진제 |
| US7649002B2 (en) * | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| CA2642922C (en) * | 2006-02-23 | 2011-08-02 | Pfizer Limited | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| EP1842846A1 (en) * | 2006-04-07 | 2007-10-10 | Santhera Pharmaceuticals (Schweiz) AG | Phenylpiperidine derivatives as melanocortin-4 receptor modulators |
-
2007
- 2007-07-19 EP EP07014219A patent/EP2019100A1/en not_active Withdrawn
-
2008
- 2008-07-18 RU RU2009147775/04A patent/RU2452734C2/ru not_active IP Right Cessation
- 2008-07-18 DK DK08784892.5T patent/DK2176250T3/da active
- 2008-07-18 US US12/665,771 patent/US20100249093A1/en not_active Abandoned
- 2008-07-18 ES ES08784892T patent/ES2371626T3/es active Active
- 2008-07-18 NZ NZ582153A patent/NZ582153A/en not_active IP Right Cessation
- 2008-07-18 SI SI200830492T patent/SI2176250T1/sl unknown
- 2008-07-18 PT PT08784892T patent/PT2176250E/pt unknown
- 2008-07-18 HR HR20110860T patent/HRP20110860T1/hr unknown
- 2008-07-18 WO PCT/EP2008/005913 patent/WO2009010299A1/en not_active Ceased
- 2008-07-18 BR BRPI0814382-0A2A patent/BRPI0814382A2/pt not_active IP Right Cessation
- 2008-07-18 AT AT08784892T patent/ATE530541T1/de active
- 2008-07-18 AU AU2008277916A patent/AU2008277916B2/en not_active Ceased
- 2008-07-18 CN CN200880025309A patent/CN101801950A/zh active Pending
- 2008-07-18 CA CA2694480A patent/CA2694480C/en not_active Expired - Fee Related
- 2008-07-18 KR KR1020107003537A patent/KR20100033541A/ko not_active Abandoned
- 2008-07-18 EP EP08784892A patent/EP2176250B1/en not_active Not-in-force
- 2008-07-18 JP JP2010516425A patent/JP2010533666A/ja not_active Ceased
- 2008-07-18 PL PL08784892T patent/PL2176250T3/pl unknown
-
2009
- 2009-12-17 IL IL202797A patent/IL202797A0/en unknown
-
2010
- 2010-01-08 ZA ZA201000153A patent/ZA201000153B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2176250A1 (en) | 2010-04-21 |
| ZA201000153B (en) | 2010-09-29 |
| PT2176250E (pt) | 2011-12-15 |
| SI2176250T1 (sl) | 2012-01-31 |
| WO2009010299A8 (en) | 2009-04-02 |
| EP2176250B1 (en) | 2011-10-26 |
| ATE530541T1 (de) | 2011-11-15 |
| BRPI0814382A2 (pt) | 2015-01-27 |
| JP2010533666A (ja) | 2010-10-28 |
| NZ582153A (en) | 2011-09-30 |
| CN101801950A (zh) | 2010-08-11 |
| ES2371626T3 (es) | 2012-01-05 |
| IL202797A0 (en) | 2010-06-30 |
| AU2008277916B2 (en) | 2012-02-02 |
| DK2176250T3 (da) | 2012-02-13 |
| CA2694480C (en) | 2012-05-15 |
| AU2008277916A1 (en) | 2009-01-22 |
| KR20100033541A (ko) | 2010-03-30 |
| RU2452734C2 (ru) | 2012-06-10 |
| CA2694480A1 (en) | 2009-01-22 |
| US20100249093A1 (en) | 2010-09-30 |
| HRP20110860T1 (hr) | 2011-12-31 |
| EP2019100A1 (en) | 2009-01-28 |
| WO2009010299A1 (en) | 2009-01-22 |
| RU2009147775A (ru) | 2011-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201000153B (en) | Substituted heteroarylpiperidine derivatives as melano-cortin-4-receptor modulators | |
| ATE490239T1 (de) | Substituierte phenylpiperidinderivate als melanocortin-4-rezeptormodulatoren | |
| MX2009010429A (es) | Derivados de imidazopiridina sustituidos como antagonistas de receptor de melanocortina-4. | |
| WO2004083208A8 (en) | Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators | |
| TN2011000463A1 (en) | Composition and methods for increasing muscle growth | |
| CY1111477T1 (el) | Θειενοπυριδινες ως αλλοστερικοι ενισχυτες του μ4 μουσκαρινικου υποδοχεα | |
| GEP20135793B (en) | Heteroaryls amide derivatives and their use as glucokinase activators | |
| UA83311C2 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| NO20076344L (no) | Piperazin-piperidin-antagonister og agonister av 5-HT1A-reseptoren | |
| UA96447C2 (ru) | Полиморфные формы (2s)-(4e)-n-метил-5-[3-(5-изопропоксипиридин)ил]-4-пентен-2-амина для лечения расстройств центральной нервной системы | |
| TW200608966A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| MX2010004003A (es) | N-fenil-pirrolidinilmetlipirrolidin amidas sustituidas y uso terapeutico de las mismas. | |
| UA83917C2 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
| IL189974A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
| BRPI0812366A2 (pt) | composto, composição farmacêutica e métodos de modulação de um ou mais subtipos de gabaa, de tratamento de deficiência orgânica cognitiva e de desordem psiquiátrica e aumento de função cognitiva em animal e usos do composto ou da composição. | |
| MXPA05012081A (es) | Derivados de pirimidina sustituidos. | |
| ATE367391T1 (de) | Substituierte piperidin- und piperazin-derivate als melanocortin-4 rezeptor modulatoren | |
| ATE362368T1 (de) | Substituierte piperidin- und piperazin-derivative als melanocortin-4 receptor modulatoren | |
| WO2007131153A3 (en) | Methods for the preparation of pyrazole-containing compounds | |
| WO2007098393A3 (en) | Compounds and methods for treating diseases with trpv4 channel receptors | |
| MX2009003390A (es) | Derivados de aril piperazina utiles para el tratamiento de trastornos neuropsiquiatricos. | |
| MX2007012624A (es) | Derivados de benzimidazol y su uso para la modulacion del complejo del receptor gaba-a. | |
| SI1812417T1 (sl) | Novi derivati 2H-kromena kot selektivni modulatorji estrogenskega receptorja | |
| TW200716602A (en) | Novel compounds | |
| UA84570C2 (ru) | Производные циклопропила как антагонисты рецептора nk3 |